Skip to content

The Effects of Intradialytic Aerobic Exercise on Clinical Parameters, Coping With Illness, Perceived Benefits of Exercise and Barriers to Exercise in Haemodialysis Patients: A Randomised Controlled Trial

THE EFFECTS OF INTRADİALYTİC AEROBİC EXERCİSE ON CLİNİCAL PARAMETERS, COPİNG WİTH ILLNESS, PERCEİVED BENEFİTS OF EXERCİSE AND BARRİERS TO EXERCİSE İN HAEMODİALYSİS PATİENTS: A RANDOMİSED CONTROLLED TRİAL

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07758244
Enrollment
40
Registered
2026-08-11
Start date
2026-08-24
Completion date
2026-10-23
Last updated
2026-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis Patients

Keywords

hemodialysis, aerobic exercise, adaptation to the disease, perceived exercise benefits

Brief summary

This randomized controlled trial aims to investigate the effects of an 8-week intradialytic aerobic exercise program on clinical parameters, disease adaptation, and perceived exercise benefits and barriers in patients undergoing maintenance hemodialysis. Eligible participants will be randomly assigned to either an intervention group receiving supervised aerobic exercise during hemodialysis sessions or a control group receiving routine hemodialysis care. Aerobic exercise will be performed three times per week during hemodialysis for eight weeks. Exercise intensity will be individually adjusted according to the participant's subjective fatigue level using the 20-point Borg Rating of Perceived Exertion (RPE) scale, targeting an intensity of 11-13 ("light to somewhat hard"). Outcomes will be assessed before and after the intervention using validated clinical measurements and patient-reported outcome measures.

Interventions

OTHERExercise

The use of intradialytic aerobic exercise in hemodialysis patients.

Sponsors

Muş Alparslan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Having received hemodialysis treatment for 4 hours a day, 3 days a week, for at least 3 months.

Exclusion criteria

* Having a history of myocardial infarction within the last 3 months * Having angina pectoris or uncontrolled arrhythmia and uncontrolled hypertension * Having communication or cognitive problems to the extent that one cannot complete the required tests * Being pregnant or undergoing infertility treatment * Having a psychiatric diagnosis

Design outcomes

Primary

MeasureTime frameDescription
Dialysis Patient-Perceived Exercise Benefits and Barriers Scale (DPEBBS)Two monthsThis is a 4-point Likert scale (1- Strongly Disagree, 4- Strongly Agree). The scale consists of 24 items and two open-ended questions. It comprises five sub-dimensions: "Daily Life (7 items)", "Exercise-related Undesirable Outcomes (7 items)", "Quality of Life (4 items)", "Exercise Effects (3 items)", and "Exercise Benefits (3 items)". The daily life and exercise-related undesirable outcomes sub-dimensions represent the obstacles to exercise, while the quality of life, exercise effects, and exercise benefits sub-dimensions represent the benefits of exercise. Items 3, 4, 6, 7, 10, 13, 16, 20, 22, and 23 comprise the benefits sub-dimension; items 1, 2, 5, 8, 9, 11, 12, 14, 15, 17-19, 21, and 24 comprise the obstacles sub-dimension. The items in the DPEBBS scale that represent barrier factors are reverse-coded. The scale is evaluated based on a total score (min=24, max=96). Higher scores indicate a greater perception of exercise benefits and fewer exercise barriers.
The End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ)Two monthsThe scale, designed to assess adherence to end-stage renal failure, consists of nine questions and four sub-dimensions encompassing adherence behaviors: "hemodialysis participation," "medication adherence," "fluid restriction adherence," and "diet adherence." The total score obtainable from the scale ranges from 0 to 1200. Higher scores indicate higher adherence to treatment.

Contacts

CONTACTCengiz TAŞKAYA
c.taskaya@alparslan.edu.tr05364811882
CONTACTAbdulsamed KAYA
a1@alparslan.edu.tr05364400551
STUDY_DIRECTORCengiz TAŞKAYA

Muş Alparslan University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 12, 2026